ACE Report Cover
Topical tranexamic acid and betadine combination effective for reducing blood loss in TKA
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
Topical tranexamic acid and betadine combination effective for reducing blood loss in TKA .
Verified
This report has been verified by one or more authors of the original publication.

Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study.

Orthop Traumatol Surg Res. 2015 Feb;101(1):83-7.

125 patients undergoing total knee arthroplasty were randomized to receive either 1.5g or 3g of topical tranexamic acid (TXA) in 100mL of povidone-iodine solution, or simply the povidone-iodine solution alone into the knee before wound closure. The purpose of this study was to examine the effect of this combination of topical applications on blood loss and infection rate. Secondarily, hemoglobin, hematocrit, platelet count, and coagulation parameters were compared. The results indicated that patients receiving tranexamic acid displayed higher hemoglobin levels, and less blood loss, with no difference in complication rates, when compared to the control group.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Topical tranexamic acid and betadine combination effective for reducing blood loss in TKA. ACE Report. 2015;4(4):74. Available from: https://myorthoevidence.com/AceReport/Show/topical-tranexamic-acid-and-betadine-combination-effective-for-reducing-blood-loss-in-tka

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report